Phibro Animal Health's (PAHC) "Hold (C)" Rating Reiterated at Weiss Ratings

Key Points

• Phibro Animal Health's stock maintains a "Hold (C)" rating from Weiss Ratings, with an average price target of $28.40 from analysts.
• The company reported a quarterly earnings per share (EPS) of $0.57, exceeding expectations of $0.52, with revenue of $378.70 million compared to estimates of $362.24 million.
• Recent insider activity includes CEO Jack Bendheim selling over 7,000 shares, decreasing his ownership by 18.31%, while 99.34% of the company's stock is held by institutional investors.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report)'s stock had its "hold (c)" rating restated by research analysts at Weiss Ratings in a note issued to investors on Tuesday,Weiss Ratings reports.

Several other brokerages have also issued reports on PAHC. BNP Paribas raised shares of Phibro Animal Health to a "hold" rating in a research note on Monday, June 16th. Bank of America increased their price target on shares of Phibro Animal Health from $19.00 to $27.00 and gave the company an "underperform" rating in a research report on Friday, August 29th. BNP Paribas Exane upgraded shares of Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price target on the stock in a research report on Monday, June 16th. JPMorgan Chase & Co. upgraded shares of Phibro Animal Health from a "neutral" rating to an "overweight" rating and increased their price target for the company from $25.00 to $35.00 in a research report on Monday, July 7th. Finally, Zacks Research upgraded shares of Phibro Animal Health from a "hold" rating to a "strong-buy" rating in a research report on Monday, September 29th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, four have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, Phibro Animal Health currently has an average rating of "Hold" and an average price target of $28.40.

Phibro Animal Health Price Performance

NASDAQ:PAHC traded up $0.77 during mid-day trading on Tuesday, reaching $37.35. 59,054 shares of the company were exchanged, compared to its average volume of 274,238. Phibro Animal Health has a 12 month low of $16.16 and a 12 month high of $41.57. The company has a fifty day moving average of $35.85 and a 200 day moving average of $27.93. The company has a quick ratio of 1.25, a current ratio of 2.76 and a debt-to-equity ratio of 2.46. The stock has a market cap of $1.51 billion, a PE ratio of 31.65, a PEG ratio of 1.10 and a beta of 0.83.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its quarterly earnings data on Wednesday, August 27th. The company reported $0.57 EPS for the quarter, topping analysts' consensus estimates of $0.52 by $0.05. Phibro Animal Health had a net margin of 3.73% and a return on equity of 32.14%. The firm had revenue of $378.70 million for the quarter, compared to analyst estimates of $362.24 million. Phibro Animal Health has set its FY 2026 guidance at 2.520-2.700 EPS. On average, research analysts anticipate that Phibro Animal Health will post 1.95 EPS for the current fiscal year.

Insider Activity

In other news, CEO Jack Bendheim sold 7,022 shares of Phibro Animal Health stock in a transaction that occurred on Thursday, September 18th. The shares were sold at an average price of $40.26, for a total value of $282,705.72. Following the sale, the chief executive officer directly owned 31,338 shares in the company, valued at $1,261,667.88. This trade represents a 18.31% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders have sold 24,622 shares of company stock valued at $995,893 in the last 90 days. 50.13% of the stock is owned by company insiders.

Institutional Trading of Phibro Animal Health

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. GAMMA Investing LLC increased its holdings in Phibro Animal Health by 2,011.4% during the first quarter. GAMMA Investing LLC now owns 36,718 shares of the company's stock worth $784,000 after buying an additional 34,979 shares during the last quarter. Sowell Financial Services LLC bought a new stake in shares of Phibro Animal Health in the first quarter valued at about $1,977,000. Cardinal Capital Management grew its stake in shares of Phibro Animal Health by 9.6% in the first quarter. Cardinal Capital Management now owns 75,010 shares of the company's stock valued at $1,602,000 after acquiring an additional 6,568 shares in the last quarter. Principal Financial Group Inc. grew its stake in shares of Phibro Animal Health by 2.6% in the first quarter. Principal Financial Group Inc. now owns 101,356 shares of the company's stock valued at $2,165,000 after acquiring an additional 2,573 shares in the last quarter. Finally, Jackson Creek Investment Advisors LLC bought a new stake in Phibro Animal Health during the first quarter worth about $1,411,000. 99.34% of the stock is currently owned by institutional investors and hedge funds.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.